Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2253 of 6351
-
Swallow a sponge to catch cancer early?
Diagnosis By invitation onlyThis study explores the use of a minimally invasive screening tool (a sponge on a string device) to detect Barrett's esophagus and esophageal adenocarcinoma and to develop a laboratory test for the detection of Barrett's esophagus-high grade dysplasia and esophageal adenocarcinom…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New ankle pain shot could cut opioid use after surgery
Symptom relief Recruiting nowThe goal of this clinical study is to learn about pain management strategies in subjects undergoing total ankle replacement. arthroplasty surgery The primary objective is to compare the magnitude of the analgesic effect following a single dose injection of EXPAREL vs. 0.25% bupiv…
Phase 3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Real-World check: does new IBD drug guselkumab deliver in the clinic?
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the outcomes of treatment (clinical outcomes) in adult participants with moderately to severely active Ulcerati…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Smart diabetes monitoring trial aims to improve insulin management
Disease control Recruiting nowThe trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a telemonitoring group (control), and a usual care group (control). Both the intelligent telemonitoring group an…
Sponsor: Aalborg University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Shock wave therapy: finding the right frequency for kids with CP
Symptom relief CompletedSpasticity is a major contributor to functional limitations in children with cerebral palsy. Radial extracorporeal shock wave therapy (rESWT) has emerged as a non-invasive method for reducing spasticity; however, the optimal session frequency remains unclear. This randomized, ass…
Sponsor: Sisli Hamidiye Etfal Training and Research Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a herbal formula restore hearing? new trial investigates
Disease control Recruiting nowThis project aims to evaluate the clinical efficacy of Yiyuancong, an independently developed traditional Chinese medicine (TCM) formula based on the homology of medicine and food, in participants with sudden sensorineural hearing loss (SSNHL) and to elucidate its potential under…
Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a higher dose of allergy medicine beat hives faster?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether a higher dose of cetirizine works better than the standard dose to relieve symptoms of acute urticaria (hives) in adults. The study also aims to learn about the safety of taking a higher dose for a short period of time. The main…
Sponsor: University of Phayao • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Could an immune booster beat long COVID? small trial begins
Disease control Recruiting nowThis study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and have follow-up exams and tests.
Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New stomach-shrinking tools battle bulge without surgery
Disease control Recruiting nowevaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Sponsor: Nitinotes Surgical Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New gel could speed healing of chronic wounds
Disease control Recruiting nowThis prospective, randomized, single-blind, controlled clinical investigation evaluates the efficacy and safety of ZKARE®, a topical polymeric gel dressing, and its accessory applicator ZKAPI®, for the treatment of chronic, hard-to-heal ulcers. The study includes 134 ulcers of di…
Sponsor: i+Med S.Coop. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental drug PA5 targets arginine to starve advanced cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn if PA5 is safe and works to treat advanced solid tumors in adults. It will also learn about the tolerability and PK/PD profile of PA5. The main questions it aims to answer are: * Is intravenous infusion of PA5 monotherapy safe and tole…
Phase 1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Stem cell byproduct may boost ACL graft healing — trial puts it to the test
Disease control CompletedAnterior cruciate ligament (ACL) reconstruction is commonly performed to restore knee stability after ACL injury; however, graft healing remains a critical determinant of successful outcomes. This randomized, double-blind, placebo-controlled trial evaluated the efficacy and safet…
Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for chronic constipation: lubiprostone in Late-Stage trial
Symptom relief Recruiting nowLubiprostone has established efficacy and a favorable safety profile in chronic constipation and irritable bowel syndrome with constipation (IBS-C). However, clinical data specifically supporting its use in slow-transit constipation (STC), a distinct subtype of chronic constipati…
Phase 3 • Sponsor: Third Military Medical University • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New drug EVOLVE104 takes on tough cancers in early human trial
Disease control Recruiting nowThe goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have previously taken standard treatment options, have declined or have been ineligible for treatment with these medications. …
Phase 1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug trial aims to improve lung function in fibrosis patients
Disease control Recruiting nowThis study is open to adults who are at least 40 years old and have idiopathic pulmonary fibrosis (IPF). People can participate in the study if they have a forced vital capacity (FVC) greater than or equal to 45% of the predicted value and fibrosis of 20% or more confirmed by a h…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill combo aims to crush bad cholesterol
Disease control OngoingThis is a study to investigate the effect of AZD0780 tablets on low density lipoprotein cholesterol levels (LDL-C) compared with placebo tablets administered in combination with rosuvastatin tablets in adult Russian participants with dyslipidaemia. AZD0780 is a small molecule tha…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a sticky film shield breast cancer patients from radiation burns in tropical heat?
Disease control Recruiting nowPrimary Objective To examine the tolerability of Mepitel Film in the prevention of RD patients undergoing whole breast or chest wall RT in the hot and humid weather in Singapore Secondary Objectives To evaluate the incidence of acute radiation dermatitis, quality of life, satisf…
Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New eye injection shows promise for wet AMD in everyday practice
Disease control Recruiting nowThe goal of this observational study is to explore the effectiveness of aflibercept 8 mg in treating both treatment-naive and previously treated patients with neovascular age-related macular degeneration (nAMD) in a real-world setting. The main questions it aims to answer are: W…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New heart valve fix could spare High-Risk patients from major surgery
Disease control Recruiting nowParticipants with severe tricuspid regurgitation may require heart surgery to repair or replace the tricuspid valve. However, there is a high risk associated with these surgeries and it is often not feasible for elderly patients or those with other medical conditions. The goal o…
Sponsor: Tau Medical Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study questions rush to antibiotics for ventilator lung infections
Disease control Recruiting nowVentilator-associated pneumonia is the leading nosocomial infection in the intensive care units, and is associated with prolonged mechanical ventilation and overuse of antibiotics. Initiating antibiotic therapy immediately after bacteriological sampling (immediate strategy) may e…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC